IART
Integra LifeSciences Holdings
12.70$
-21.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 42.9% | 43.0% | 43.9% | 46.0% | 47.4% | 43.7% | 49.2% | 49.6% | 43.8% | 50.5% | 42.8% | 47.5% | 46.3% | |
| 57.1% | 57.0% | 56.1% | 54.0% | 52.6% | 56.3% | 50.8% | 50.4% | 56.2% | 49.5% | 57.2% | 52.5% | 53.7% | |
| 7.0% | 6.1% | 7.3% | 7.1% | 7.2% | 7.1% | 6.5% | 6.5% | 5.6% | 5.7% | 6.0% | 5.8% | 5.8% | |
| 42.3% | 41.1% | 44.9% | 46.7% | 46.5% | 40.3% | 47.4% | 43.3% | 42.0% | 38.9% | 45.5% | 41.2% | 41.8% | |
| 50.1% | 48.0% | 55.0% | 54.7% | 54.7% | 48.2% | 54.9% | 173.7% | 46.2% | -78.4% | 47.0% | 47.9% | 13.9% | |
| 7.0% | 9.1% | 1.1% | -0.7% | -2.1% | 8.0% | -4.0% | -123.4% | 10.0% | 127.9% | 10.2% | 4.6% | 39.8% | |
| 3.4% | 3.5% | 3.7% | 4.5% | 5.1% | 4.3% | 5.3% | 5.1% | 5.7% | 5.4% | 6.8% | 5.5% | 5.8% | |
| 4.9% | 7.3% | -1.4% | -3.6% | -5.3% | 5.1% | -7.8% | -127.8% | -1.7% | 1.0% | -0.6% | 1.1% | 0.0% | |
| -0.2% | 2.3% | -0.5% | -0.7% | -2.5% | 0.7% | -1.2% | -11.3% | -0.4% | 1.4% | 0.6% | 0.1% | 0.4% | |
| 5.1% | 5.0% | -0.9% | -3.0% | -2.8% | 4.4% | -6.6% | -116.5% | -1.3% | -0.4% | -1.2% | 1.1% | -0.4% | |
| 16.3% | 18.5% | 10.6% | 9.6% | 9.2% | 17.9% | 6.8% | -113.6% | 13.4% | 15.2% | 16.0% | 15.7% | 15.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.